HRP20060236A2 - Calcitonin gene related peptide receptor antagonists - Google Patents
Calcitonin gene related peptide receptor antagonistsInfo
- Publication number
- HRP20060236A2 HRP20060236A2 HR20060236A HRP20060236A HRP20060236A2 HR P20060236 A2 HRP20060236 A2 HR P20060236A2 HR 20060236 A HR20060236 A HR 20060236A HR P20060236 A HRP20060236 A HR P20060236A HR P20060236 A2 HRP20060236 A2 HR P20060236A2
- Authority
- HR
- Croatia
- Prior art keywords
- related peptide
- treatment
- peptide receptor
- receptor
- receptor antagonists
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Predstavljeni izum se odnosi na Spojeve Formule (I), kao antagoniste receptora za peptid povezan sagenom za kalcitonin ("CGRP-receptor"), farmaceutske smjese koje ih sadrže, postupke za njihovu identifikaciju, postupke za liječenje njihovom primjenom i na njihovu primjenu u terapiji za liječenje neurogene vazodilatacije, neurogene upale, migrene i druge glavobolje, termalne povrede, cirkulatornog šoka, nastupa crvenila koje je povezano sa menopauzom, upalnih bolesti dišnih puteva, kao što su astma i kronična opstruktivna bolest pluća (COPD), kao i ostalih stanja čije se liječenje može postići preko antagonizma CGRP-receptora.The present invention relates to Compounds of Formula (I), as antagonists of the calcitonin sage-related peptide receptor ("CGRP-receptor"), pharmaceutical mixtures containing them, procedures for their identification, procedures for treatment using them and their use in therapy for the treatment of neurogenic vasodilatation, neurogenic inflammation, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, inflammatory diseases of the respiratory tract, such as asthma and chronic obstructive pulmonary disease (COPD), as well as other conditions whose treatment can be achieved through CGRP-receptor antagonism.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HR20060236A HRP20060236A2 (en) | 2003-12-05 | 2006-07-04 | Calcitonin gene related peptide receptor antagonists |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2003/038799 WO2005065779A1 (en) | 2003-12-05 | 2003-12-05 | Calcitonin gene related peptide receptor antagonists |
HR20060236A HRP20060236A2 (en) | 2003-12-05 | 2006-07-04 | Calcitonin gene related peptide receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20060236A2 true HRP20060236A2 (en) | 2006-10-31 |
Family
ID=37114582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20060236A HRP20060236A2 (en) | 2003-12-05 | 2006-07-04 | Calcitonin gene related peptide receptor antagonists |
Country Status (1)
Country | Link |
---|---|
HR (1) | HRP20060236A2 (en) |
-
2006
- 2006-07-04 HR HR20060236A patent/HRP20060236A2/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062489L (en) | Heterocyclic anti-migraine agents | |
NO20062648L (en) | Calcitonin gene related peptide receptor antagonists | |
TW200407327A (en) | Calcitonin gene related peptide receptor antagonists | |
NO20064888L (en) | Heterocyclic CGRP antagonists for the treatment of migraine | |
TW200628470A (en) | Constrained compounds as CGRP-receptor antagonists | |
EP2582432B1 (en) | Ureido-pyrazole derivatives for use in the treatment of rhinovirus infections | |
TN2012000139A1 (en) | Cgrp receptor antagonists | |
CL2008001898A1 (en) | Pyrazinone derived compounds, p38 inhibitors; process of preparing these; pharmaceutical composition comprising them; pharmaceutical combination comprising them; use to treat chronic obstructive pulmonary diseases and asthma. | |
WO2009126530A3 (en) | Piperidine derivatives as cgrp receptor antagonists | |
EA201200876A1 (en) | NEW ANTAGONISTS CCR2 RECEPTOR AND THEIR APPLICATION | |
CU23497A3 (en) | DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS | |
SE0200356D0 (en) | Novel use | |
WO2007130860A3 (en) | Constrained compounds as cgrp-receptor antagonists | |
EA201270751A1 (en) | ANTAGONIST RECEPTOR CGRP | |
ATE517903T1 (en) | COMPOUNDS WITH RESTRICTED CONFORMATION AS CGRP RECEPTOR ANTAGONISTS. | |
NO20084564L (en) | Tight "Constrained" Compounds as CGRP Receptor Antagonists | |
UY30935A1 (en) | COMBINATION: -ANTAGONIST OF THE CHEMIOQUINE RECEIVER 1 (CCR1) -AGONIST OF THE GLUCOCORTICOID RECEPTOR- OPTIONALLY AGONIST B (BETA) 2, - PHARMACEUTICAL COMPOSITION CONTAINING IT - APPLICATIONS. | |
NI200700039A (en) | DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS. | |
EP2079725B1 (en) | Piperidyl-propane-thiol ccr3 modulators | |
HRP20060236A2 (en) | Calcitonin gene related peptide receptor antagonists | |
CA2667548A1 (en) | Substituted piperidyl-propane-thiols | |
TH65848B (en) | Resistor anthracite for calcitonin rylate peptide | |
TH78134A (en) | Resistor anthracite for calcitonin rylate peptide | |
TH87766A (en) | Heterocyclic anti-migraine agents | |
TH87766B (en) | Heterocyclic anti-migraine agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20091204 Year of fee payment: 7 |
|
OBST | Application withdrawn |